‘Definitive test’ finds exercise a potent weapon against colon cancer
On Jun. 2, 2025, a first-of-its-kind international trial provides definitive evidence that people who follow a structured exercise program…
On Jun. 2, 2025, a first-of-its-kind international trial provides definitive evidence that people who follow a structured exercise program…
On May 30, 2025, Pfizer announced statistically significant and clinically meaningful survival results from the Phase 3 BREAKWATER…
On May 23, 2025 a Boston University School of Public Health (BUSPH) led study revealed that there were…
On May 21, 2025, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it has approved…
On May 20, 2025, the World Health Organization (WHO) announced that world leaders pledged at least an additional…
On May 14, 2025, The U.S. Food and Drug Administration (FDA) has approved AbbVie’s drug to treat adults…
On May 9, 2025, Teal Health® announced the Food and Drug Administration’s (FDA) approval of the Teal Wand™,…
On My 7, 2025, researchers at the University College London (UCL) and King’s College London announced that an…
On May 6, 2025, in a first-of-its-kind surgery, a multidisciplinary team led by a University of Maryland Medical…
On May 5, 2025, The European Union (EU) and France announced half a billion euros worth of incentives…
On My 2, 2025, researchers at the Wellcome Sanger Institute, UCL, and the University of Cambridge announced they…
On May 1, 2025, the U.S. National Institutes of Health (NIH), the world’s largest funder of biomedical research,…
On Apr. 23, 2025, researchers from the Wellcome Sanger Institute, University of California San Diego and their collaborators…
On Apr. 21, 2025, the National Institutes of Health (NIH) reported that overall death rates from cancer declined steadily among…
On Apr. 21, 2025, LifeScienceHistory.com published the cartoon: “The National Institutes of Health (NIH) and U.S. Healthcare in…
On Apr. 11, 2025, the UK National Institute for Health and Care Excellence (NICE) recommended capivasertib (also called…
On Apr. 10, 2025, the U.S. Food and Drug Administration announced it is taking a groundbreaking step to…
On Apr. 8, 2025, the National Security Commission on Emerging Biotechnology delivered its major report and action plan…
On Apr. 3, 2025, a collaborative research led by investigators at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center…
On Apr. 1, 2025, layoff notices began arriving for thousands of employees of the sprawling U.S. Department of…
On Mar. 24, 2025, scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto…
On Mar. 3, 2025, the Institute for Health Metrics and Evaluation reported that without urgent policy reform and…
On Feb. 24, 2025, breast cancer is the most common cancer in women worldwide, but survival chances vary…
On Feb. 19, 2025, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
On Feb. 19, 2025, research from the Texas A&M College of Veterinary Medicine and Biomedical Sciences has discovered…
On Feb. 17, 2025, researchers from Texas Children’s Hospital in Houston announced that the four year old girl…
On Feb. 17, 2025, Stanford researchers have conducted the first large-scale screen of these inherited changes, called single…
On Feb. 5, 2025, scientists from the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and…
Jan. 24, 2025, the U.S. Food and Drug Administration (FDA) pulled draft guidance from its website requiring companies…
On Jan. 15, 2025, the U.S. Food and Drug Administration (FDA) announced revoking the authorization for the use…